76 related articles for article (PubMed ID: 1283279)
1. [Cytokines and malignant lymphomas].
Feller AC; Merz H
Verh Dtsch Ges Pathol; 1992; 76():70-8. PubMed ID: 1283279
[TBL] [Abstract][Full Text] [Related]
2. Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth.
Merz H; Fliedner A; Orscheschek K; Binder T; Sebald W; Müller-Hermelink HK; Feller AC
Am J Pathol; 1991 Nov; 139(5):1173-80. PubMed ID: 1951632
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma].
Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ
Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice.
Lange K; Uckert W; Blankenstein T; Nadrowitz R; Bittner C; Renauld JC; van Snick J; Feller AC; Merz H
Oncogene; 2003 Jan; 22(4):517-27. PubMed ID: 12555065
[TBL] [Abstract][Full Text] [Related]
5. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
6. Frequent expression of IL-7 gene transcripts in tumor cells of classical Hodgkin's disease.
Foss HD; Hummel M; Gottstein S; Ziemann K; Falini B; Herbst H; Stein H
Am J Pathol; 1995 Jan; 146(1):33-9. PubMed ID: 7856736
[TBL] [Abstract][Full Text] [Related]
7. [Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice].
Merz H; Lange K; Nadrowitz R; Uckert W; Blankenstein T; Feller AC
Verh Dtsch Ges Pathol; 2003; 87():224-31. PubMed ID: 16888916
[TBL] [Abstract][Full Text] [Related]
8. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
9. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
10. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
11. IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases.
Strauchen JA; Breakstone BA
Am J Pathol; 1987 Mar; 126(3):506-12. PubMed ID: 3103454
[TBL] [Abstract][Full Text] [Related]
12. [New immunotherapeutic approaches for the treatment of anaplastic large cell lymphoma in a mouse model].
Bittner C; Merz H; Krokowski M; Briese J; Wiedemann GJ; Feller AC
Verh Dtsch Ges Pathol; 2000; 84():187-98. PubMed ID: 11217440
[TBL] [Abstract][Full Text] [Related]
13. Cytokine deregulation in hematological malignancies: clinical and biological implications.
Kurzrock R
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2581-4. PubMed ID: 9815659
[TBL] [Abstract][Full Text] [Related]
14. IL-9 and its receptor: from signal transduction to tumorigenesis.
Knoops L; Renauld JC
Growth Factors; 2004 Dec; 22(4):207-15. PubMed ID: 15621723
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cells and immune microenvironment in malignant lymphoma.
de Jong D; Enblad G
J Intern Med; 2008 Dec; 264(6):528-36. PubMed ID: 19017177
[TBL] [Abstract][Full Text] [Related]
16. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma].
Kovrigina AM; Probatova NA
Arkh Patol; 2005; 67(4):10-6. PubMed ID: 16209291
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
19. Cytokines in malignant lymphomas: review and prospective evaluation.
Hsu SM; Waldron JW; Hsu PL; Hough AJ
Hum Pathol; 1993 Oct; 24(10):1040-57. PubMed ID: 8406414
[TBL] [Abstract][Full Text] [Related]
20. IL-2 mRNA expression in Tac-positive malignant lymphomas.
Peuchmaur M; Emilie D; Crevon MC; Solal-Celigny P; Maillot MC; Lemaigre G; Galanaud P
Am J Pathol; 1990 Feb; 136(2):383-90. PubMed ID: 2305833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]